Evidence map›Paper›PMID 34501230›Full record

ArticleJournal of clinical medicine2021

Long COVID: Distinction between Organ Damage and Deconditioning.

Johannes Kersten, Michael Baumhardt, Paul Hartveg, Luis Hoyo, Elina Hüll, Armin Imhof, Cornelia Kropf-Sanchen, Nicoleta Nita, Johannes Mörike, Manuel Rattka and 7 more

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 2 pooled it
3.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 2 syntheses or guidelines pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. ESCMID rapid guidelines for assessment and management of long COVID.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2022
    Guideline
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. The Bidirectional Association Between Metabolic Syndrome and Long-COVID-19.Diabetes, metabolic syndrome and obesity : targets and therapy · 2024
    Review
  12. Postacute Sequelae of SARS-CoV-2: Musculoskeletal Conditions and Pain.Physical medicine and rehabilitation clinics of North America · 2023
    Review
  13. Article
  14. [The problem of long/post-COVID in expert assessments].Unfallchirurgie (Heidelberg, Germany) · 2023
    Review
  15. Article
  16. Article
  17. Long COVID and hypertension-related disorders: a report from the Japanese Society of Hypertension Project Team on COVID-19.Hypertension research : official journal of the Japanese Society of Hypertension · 2023
    Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 1 institution in 1 country.

Johannes KerstenDepartment for Internal Medicine II, University of Ulm, 89081 Ulm, Germany.ORCID 0000-0003-0165-9977
Michael BaumhardtDepartment for Internal Medicine II, University of Ulm, 89081 Ulm, Germany.
Paul HartvegDepartment for Internal Medicine II, University of Ulm, 89081 Ulm, Germany.
Luis HoyoDepartment for Internal Medicine II, University of Ulm, 89081 Ulm, Germany.
Elina HüllDepartment for Internal Medicine II, University of Ulm, 89081 Ulm, Germany.
Armin ImhofDepartment for Internal Medicine II, University of Ulm, 89081 Ulm, Germany.
Cornelia Kropf-SanchenDepartment for Internal Medicine II, University of Ulm, 89081 Ulm, Germany.
Nicoleta NitaDepartment for Internal Medicine II, University of Ulm, 89081 Ulm, Germany.
Johannes MörikeDepartment for Internal Medicine II, University of Ulm, 89081 Ulm, Germany.ORCID 0000-0002-2516-8630
Manuel RattkaDepartment for Internal Medicine II, University of Ulm, 89081 Ulm, Germany.
Stefanie AndreßDepartment for Internal Medicine II, University of Ulm, 89081 Ulm, Germany.
Dominik ScharnbeckDepartment for Internal Medicine II, University of Ulm, 89081 Ulm, Germany.
Gerlinde Schmidtke-SchrezenmeierDepartment for Internal Medicine II, University of Ulm, 89081 Ulm, Germany.
Marijana TadicDepartment for Internal Medicine II, University of Ulm, 89081 Ulm, Germany.
Alexander WolfDepartment for Internal Medicine II, University of Ulm, 89081 Ulm, Germany.
Wolfgang RottbauerDepartment for Internal Medicine II, University of Ulm, 89081 Ulm, Germany.
Dominik BuckertDepartment for Internal Medicine II, University of Ulm, 89081 Ulm, Germany.
Universität Ulm · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

(1) Background: Long COVID syndrome refers to long-term sequelae of the novel viral disease, which occur even in patients with initially mild disease courses. However, there is still little evidence of the actual organic consequences and their frequency, and there is no standardized workup to diagnose long COVID syndrome yet. In this study, we aim to determine the efficiency of a stepwise diagnostic approach for reconvalescent COVID-19 patients with cardiopulmonary symptoms. (2) Methods: The diagnostic workup for long COVID syndrome included three steps. In the first step, the focus was on broad applicability (e.g., blood tests and body plethysmography). In the second step, cardiopulmonary exercise testing (CPET) and cardiac MRI (CMR) were used. The third step was tailored to the individual needs of each patient. The observation period lasted from 22 February to 14 May 2021. (3) Results: We examined 231 patients in our long COVID unit (mean [SD] age, 47.8 [14.9], 132 [57.1%] women). Acute illness occurred a mean (SD) of 121 (77) days previously. Suspicious findings in the first visit were seen in 80 (34.6%) patients, prompting further diagnostics. Thirty-six patients were further examined with CPET and CMR. Of those, 16 (44.4%) had pathological findings. The rest had functional complaints without organ damage ("functional long COVID"). Cardiopulmonary sequelae were found in asymptomatic as well as severe courses of the initial COVID-19 disease. (4) Conclusions: A structured diagnostic pathway for the diagnosis of long COVID syndrome is practicable and rational in terms of resource allocation. With this approach, manifest organ damage can be accurately and comprehensively diagnosed and distinguished from functional complaints.

Indexed as

cardiac sequelaeCOVID-19long COVIDPost-COVIDpulmonary sequelae

Identifiers

PMID34501230
PMCPMC8432179
OpenAlexW3196284494

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.